|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BioSante Pharmaceuticals Inc., of Lincolnshire, Ill., said it received a U.S. patent relating to its calcium phosphate nanoparticles (CAP). CAP consists of microscopic particles of calcium phosphate, a natural compound found in teeth and bones.
Genome Therapeutics Corp., of Waltham, Mass., was awarded U.S. Patent No. 6,380,370 to cover key genetic sequences of the bacterial pathogen Staphylococcus epidermis, which forms biofilms.
Genset SA, of Paris, was allowed a U.S. patent related to fluorescent probes used in multicolor fluorescent in situ hybridization methods and principally in chromosomal painting.
Hybridon Inc., of Cambridge, Mass., was ...